Latest News

Endovascular Engineering raises US$42 million in Series B financing

Endovascular Engineering (E2) has secured US$42 million in an oversubscribed Series B financing to advance its next-generation clot removal technology platform for venous thromboembolism...

Features

Thrombectomy gold rush set to follow ATTRACT study, experts argue

At the recent Endo Vascular Access (EVA) meeting (14–15 June, Patras, Greece), Ziv Haskal (University of Virginia School of Medicine, Charlottesville, USA) spoke to...

MedTech Insights: “This is a pivotal year for us,” says VeinWay...

With seven compassionate-use cases under its belt and commercialization in view, VeinWay—developer of the Traversa, a tool for crossing tough venous occlusions—is at a...

Videos

Before the STEVECO trial, there were no randomized controlled trial data in the chronic disease space; in its wake, has come a more robust landscape to establish an evidence base: During the 2024 Charing Cross (CX) International Symposium (April...

Kush Desai

Gloria Salazar

Manj Gohel